Dijous 11 de juny, el Dipòsit Digital no estarà operatiu de 15:00 a 17:00 h per tasques de manteniment. Disculpeu les molèsties.
El jueves 11 de Junio, el Dipòsit Digital no estará operativo de 15:00 a 17:00 h debido a tareas de mantenimiento. Disculpen las molestias.
Thursday, Jun 11th, the Digital Repository will be unavailable due to a system update.

Document type

Article

Version

Accepted version

Publication date

Publication license

cc-by-nc-nd (c) Antolín Concha et. al., 2020
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/174777

Suicide mortality and use of psychotropic drugs in patients hospitalized due to bipolar disorder: A Finnish nationwide cohort study

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Background:Knowledge on the comparative effectiveness of pharmacological treatments to prevent suicidemortality in bipolar disorder is still lacking.Methods:We studied the risk of suicide mortality during 1996-2012 among all patients who had been hospi-talized due to bipolar disorder in Finland (n = 18,018; mean follow-up time 7.2 years) using nation-widedatabases. We used a Cox proportional hazards model. Analyses were adjusted for the effects of time sincediagnosis, order of treatments, current use of other treatments, polypharmacy, number of suicidal hospitaliza-tions within 2 year (indicator of inherent risk of relapse), age at index date, sex, and calendar year of index date.In secondary analysis, the first 30 days were omitted from analysis after initiation of a psychopharmacologicaltreatment to control for protopathic bias.Results:In comparison between use and no use among specific agents, only lithium (HR 0.33, 95%CI 0.24-0.47,p<0.0001) and valproic acid (HR 0.61, 95%CI 0.48-0.79, p=0.0002) were associated with a significantly de-creased risk of suicide in bipolar disorder. Lithium showed a 42% lower risk for suicide mortality compared tovalproic acid (HR 0.58, 95% CI 0.39-0.86, p = 0.007). Hypnotics were associated with a significantly (HR 1.52,95%CI 1.22-1.90, p=0.0002) higher risk of suicide.Limitations:Only hospitalized patients were included.Conclusions:Lithium should be considered as treatment of choice for patients with bipolar disorder who are athigh risk for suicide. Hypnotic use among suicidal patients indicates need for close monitoring of these patients.

Citation

Citation

ANTOLÍN CONCHA, Diego, et al. Suicide mortality and use of psychotropic drugs in patients hospitalized due to bipolar disorder: A Finnish nationwide cohort study. Journal of Affective Disorders. 2020. Vol. 277, num. 885-892. ISSN 0165-0327. [consulted: 10 of June of 2026]. Available at: https://hdl.handle.net/2445/174777

Export metadata

JSON - METS

Share record